Study demonstrates use of decisiondx®-melanoma to guide treatment decisions resulted in earlier detection of melanoma with decreased metastatic tumor burden compared to patients without surveillance imaging studies

Friendswood, texas--(business wire)---- $cstl #cstl--castle announced the publication of an independent, multi-center study of its decisiondx®-melanoma test in the archives of dermatological research.

CSTL Ratings Summary

CSTL Quant Ranking